Compare TOUR & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TOUR | VANI |
|---|---|---|
| Founded | 2006 | 1998 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.0M | 91.9M |
| IPO Year | 2014 | 2014 |
| Metric | TOUR | VANI |
|---|---|---|
| Price | $0.67 | $1.38 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 131.9K | ★ 319.1K |
| Earning Date | 03-13-2026 | 11-13-2025 |
| Dividend Yield | ★ 5.45% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $78,261,883.00 | N/A |
| Revenue This Year | $12.27 | N/A |
| Revenue Next Year | $10.18 | N/A |
| P/E Ratio | $101.02 | ★ N/A |
| Revenue Growth | ★ 9.07 | N/A |
| 52 Week Low | $0.62 | $0.91 |
| 52 Week High | $1.17 | $1.92 |
| Indicator | TOUR | VANI |
|---|---|---|
| Relative Strength Index (RSI) | 40.73 | 53.14 |
| Support Level | $0.62 | $1.23 |
| Resistance Level | $0.70 | $1.57 |
| Average True Range (ATR) | 0.03 | 0.09 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 1.78 | 46.90 |
Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.